Medicine & Life Sciences
ceftazidime drug combination avibactam
100%
Infections
89%
Coronavirus
75%
Toxoplasma
72%
Stenotrophomonas maltophilia
63%
Immunocompromised Host
58%
Neoplasms
55%
Bacteremia
52%
Parasites
51%
Histone Acetyltransferases
49%
Cephalosporins
48%
Carbapenems
47%
Blood Culture
46%
Escherichia coli
44%
Whole Genome Sequencing
41%
Escherichia coli Infections
38%
Diarrhea
38%
Nuclear Localization Signals
35%
Enteropathogenic Escherichia coli
34%
human KAT2A protein
33%
Pandemics
32%
Levofloxacin
30%
Nucleic Acid Amplification Techniques
30%
Nucleic Acids
29%
Disk Diffusion Antimicrobial Tests
29%
Ceftazidime
29%
Severe Acute Respiratory Syndrome
28%
Human Influenza
27%
Mass Spectrometry
27%
beta-1,3-D-glucan
26%
Polymerase Chain Reaction
26%
tazobactam drug combination ceftolozane
25%
Kingella kingae
25%
Lactams
25%
Stem Cells
24%
Molecular Epidemiology
24%
Interleukin-12 Receptors
24%
Lasers
24%
Enterobacteriaceae Infections
23%
polysaccharide-K
23%
Transplant Recipients
23%
Nontuberculous Mycobacterium Infections
22%
polyglucosan
22%
Eukaryotic Initiation Factor-2
22%
Antimicrobial Stewardship
22%
Yersinia Infections
22%
Ehrlichiosis
22%
Carbapenem-Resistant Enterobacteriaceae
21%
Transplants
21%